The evolutionary history of SARS-CoV-2, studies of the distribution dynamics of COVID-19, and a complex of genomic studies are given in /1,3-7/.
We have compiled graphs showing the statistics of mortality from coronavirus depending on the age and type of chronic diseases according to the China Center for Disease Control and Prevention, Fig.2.
Figure 2: Coronavirus mortality statistics in%: 1 - depending on age; 2 - depending on chronic diseases.
(These conclusions are based on 72,314 cases studied according to the /9/).
A study by Chinese scientists /8/ based on a statistical analysis of coronavirus patients in Wuhan Pulmonary Hospital and Jinyintan Hospital in Wuhan revealed very important trends and patterns of the main risk groups for Covid-19 infection. The following is table 2 given in /8/.
Studying the data in table 2 and graphs in figure 2. we understand that one of the main tasks for scientists is the development of methods and appropriate drugs that can minimize the likelihood of a decrease in immunity and the possibility of infection with coronavirus for people with a high risk of morbidity.
The categories of high mortality from coronavirus include people with concomitant diseases of the cardiovascular system (13.2%), diabetes (9.2%), hypertension (8.4%), chronic respiratory diseases (8%) and cancer patients ( 7.6%).
By age categories, old people aged ≥80 years old (maximum risk), 70-79 years old (very high risk), 60-69 years old (high risk) are at maximum risk.
Currently, many research institutes, universities and medical institutions of the world are involved in the development of an effective vaccine against COVID-19, in which leading scientists of various fields of science participate: medicine, microbiology, virology, pharmaceuticals, genetic engineering, biochemistry, biophysics and others. Scientists from China, the USA, Russia, Israel, Great Britain, France and other countries have already reported on their first successes.
Figure 3: This image showing SARS-CoV-2. The spikes on the outer edge of the virus
particles resemble a crown, giving the disease its characteristic name /11/.
Table 2. Characteristics, interventions and outcomes of the study population in Wuhan Pulmonary Hospital and Jinyintan Hospital.
In figure 3. shown transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the US, emerging from the surface of cells cultured in the laboratory. If we can see our enemy Covid-19, then why can't we defeat him?
In mid-March, the World Health Organization listed 41 candidate vaccines, which are being developed around the world. Meanwhile, according to the WHO, until the complete development of the coronavirus vaccine and its practical use, it will take at least one year /10/ and some experts call the period 1.5 years. If the development of the pandemic continues according to the current scenario, in one year, according to our estimates, to 2.5 million million people around the world can die.
Scientists all over the world are directly responsible because of the helplessness of modern science before the coronavirus pandemic. We, scientists from different countries, must join forces to prevent the development of the situation according to the worst-case scenario. We should not wait idly of creating a vaccine.
In addition, the vaccine can only help those who have not yet become infected with coronavirus. And what about those millions of people infected with coronavirus at the time of the creation of the vaccine, which the vaccine will not only not help but also contraindicated? How to treat them? In the process of competition between scientists and pharmaceutical companies to create a vaccine against coronavirus, millions of predicted infected people areremain defenseless against coronavirus. Maybe it makes sense to borrow the experience of China and not wait for the vaccine to appear, but use other mechanisms to combat coronavirus?
In addition to isolation and strict adherence to hygiene rules, there are other ways to significantly reduce the rate of pandemic and minimize the risk of infection for categories of people with an increased risk of infection and death from coronavirus.
Studies by Chinese scientists on the use of traditional Chinese medicine (TCM) in the prevention and treatment of coronavirus fully confirm our opinion on the high efficiency of the use of non-drugs aimed at enhancing the body's immunity and preventing the disease in people with high risk of contracting coronavirus with chronic diseases: cardio -vascular system, diabetes, respiratory tract, cancer, etc.
So, the director of the ABSL-2 laboratory at the Institute of Traditional Chinese Medicine at the Academy of Chinese Traditional Medicine, Dr. Tsui Xiaolan, said that TCM drugs improved immunity and cured many inflammatory processes and chronic diseases of patients with coronovirus and significantly reduced the risk of mortality. Yu Yanhong, secretary of the party committee of the State Administration for Traditional Chinese Medicine and Pharmacy of the People's Republic of China, said that "Clinical observation shows that traditional Chinese medicine (TCM) has proven effective in treating more than 90% of patients with confirmed COVID-19 in mainland China." /14/
One of the ways that have great prospects in the fight against the coronavirus pandemic is the use of already known immunostimulating drugs that also have antiviral activity, primarily for pulmonary diseases, and are highly effective detoxifiers that remove toxins from the body, including those produced by viral and bacterial infections. These drugs do not always belong to the class of drugs and may be mineral nutritional supplements. In our opinion, these drugs include mineral nutritional supplements based on natural clinoptilolite zeolite. We have extensive experience in clinical and laboratory tests of one of the very effective drugs of this class - the mineral food supplement «AZEOMED». The drug «AZEOMED» was developed and successfully tested by Azerbaijani scientists in collaboration with colleagues from Germany and Austria. Its development and research was carried out in the Azerbaijan Section of the International Academy of Sciences "Health and Ecology", the International Scientific and Technical Complex "Intergeo-Tetis", the Scientific and Production Company «AZERZEOLIT», and "Yeni Tex" Ltd.
In the process of researching the drug «AZEOMED» at different times, various scientific institutes, universities, medical institutions and international organizations participated. The drug «AZEOMED» has shown good results for more than 20 years of clinical and laboratory tests, the results of which have been published in dozens of scientific articles and books /12/. Thus, as a result of clinical and laboratory tests, it was proved that the drug «AZEOMED» is effective in the prevention and treatment of pulmonary tuberculosis, pneumonia, bird flu H5N1, polio, diabetes mellitus, diseases of the gastrointestinal tract, hypertension, cardiovascular system , cancer and a some of other diseases /12,13/. In the course of clinical and experimental studies of the «AZEOMED» mineral complex, various preparations were developed based on the natural zeolite-clinoptilolite of the Aydag deposit and its compositions with some minerals and medicinal plants, vitamins and other components. These drugs showed high antiviral activity, and proved to be active detoxifiers and antioxidants.
In the process of researching the drug «AZEOMED», more than 20 patents were obtained for various prescription compositions of «AZEOMED», designed to solve various problems of human health /1-11/. A number of other drugs based on
